TY - JOUR
T1 - The recognition and treatment of amyloidosis in the critical care patient
AU - McGowan, Nancy
PY - 2006/7/1
Y1 - 2006/7/1
N2 - Primary amyloidosis is a little understood, often misdiagnosed disease. Characterized by extracellular protein deposits in tissue and vital organs, this disease gives patients a survival period of 13.2 months after diagnosis. Those patients with congestive heart failure have a median survival rate of 4 months after diagnosis. Although primary amyloidosis may be considered rare, the incidence is the same as for Hodgkin disease, chronic granulocytic leukemia, and polycythema vera. This article discusses the pathophysiology, signs and symptoms, and treatment options for primary amyloidosis. Critical care nurses should be aware of this disease to allow their patients the greatest chance of survival.
AB - Primary amyloidosis is a little understood, often misdiagnosed disease. Characterized by extracellular protein deposits in tissue and vital organs, this disease gives patients a survival period of 13.2 months after diagnosis. Those patients with congestive heart failure have a median survival rate of 4 months after diagnosis. Although primary amyloidosis may be considered rare, the incidence is the same as for Hodgkin disease, chronic granulocytic leukemia, and polycythema vera. This article discusses the pathophysiology, signs and symptoms, and treatment options for primary amyloidosis. Critical care nurses should be aware of this disease to allow their patients the greatest chance of survival.
KW - Amyloid
KW - Amyloidosis
KW - Congestive heart failure
UR - http://www.scopus.com/inward/record.url?scp=33746772015&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746772015&partnerID=8YFLogxK
U2 - 10.1097/00003465-200607000-00006
DO - 10.1097/00003465-200607000-00006
M3 - Article
C2 - 16868463
AN - SCOPUS:33746772015
VL - 25
SP - 161
EP - 164
JO - Dimensions of Critical Care Nursing
JF - Dimensions of Critical Care Nursing
SN - 0730-4625
IS - 4
ER -